Mohamed M. Sayed‐Ahmed

ORCID: 0000-0002-2179-8002
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Cancer Treatment and Pharmacology
  • Electron Spin Resonance Studies
  • Mitochondrial Function and Pathology
  • Advanced Proteomics Techniques and Applications
  • Antioxidant Activity and Oxidative Stress
  • Vitamin C and Antioxidants Research
  • Cardiovascular Function and Risk Factors
  • Peroxisome Proliferator-Activated Receptors
  • Cardiac electrophysiology and arrhythmias
  • Effects of Radiation Exposure
  • Carcinogens and Genotoxicity Assessment
  • Kruppel-like factors research
  • Chemotherapy-induced organ toxicity mitigation
  • Alcohol Consumption and Health Effects
  • High Altitude and Hypoxia
  • Silymarin and Mushroom Poisoning
  • Genomics, phytochemicals, and oxidative stress
  • Cardiac Ischemia and Reperfusion
  • Bone health and treatments
  • Synthesis of heterocyclic compounds
  • MicroRNA in disease regulation
  • Cancer Cells and Metastasis
  • Lipoproteins and Cardiovascular Health
  • Estrogen and related hormone effects

Cairo University
2001-2024

Children Cancer Hospital
1999-2024

Cancer Institute (WIA)
2001-2020

King Saud University
2006-2012

National Cancer Institute
2001

Brain Physiology Lab
2001

Clinical use of doxorubicin (DOX) is limited by its cardiotoxic side effects. Recent studies established that metformin (MET), an oral antidiabetic drug, possesses antioxidant activity. However, whether it can protect against DOX-induced energy starvation and mitochondrial damage has not been reported. Our results, in a rat model cardiotoxicity, show DOX treatment significantly increased serum levels LDH CK-MB, indicators cardiac injury, induced expression hypertrophic gene markers. also...

10.1155/2012/434195 article EN cc-by Oxidative Medicine and Cellular Longevity 2012-01-01

Doxorubicin is an antibiotic broadly used in treatment of different types solid tumors. The present study investigates whether L-carnitine, antioxidant agent, can reduce the hepatic damage induced by doxorubicin. Male Wistar albino rats were divided into six groups: group 1 intraperitoneal injected with normal saline for 10 consecutive days; 2, 3 and 4 every other day doxorubicin (3 mg/kg, i.p.), to obtain treatments cumulative doses 6, 12, 18 mg/kg. fifth was L-carnitine (200 i.p.) days...

10.4161/oxim.3.6.14416 article EN cc-by Oxidative Medicine and Cellular Longevity 2010-01-01

Interaction of doxorubicin DOX with iron and the consequent generation reactive oxygen species (ROS) is a major player in DOX-induced cardiomyopathy. Accordingly, this study has been initiated to investigate preventive effect chelator, desferrioxamine (DFX), against acute cardiotoxicity rats. Male Wistar albino rats were divided into four groups injected intraperitoneally (I.P.) normal saline, single dose (15 mg/kg), DFX (250 mg/kg) combined treatment 30 min prior DOX, mg/kg). A...

10.1155/2012/619185 article EN cc-by Oxidative Medicine and Cellular Longevity 2012-01-01

Hormonal receptor positive (HR+) breast cancer is the most commonly diagnosed molecular subtype of cancer; which showed good response to doxorubicin (DOX)-based chemotherapy. Eugenol (EUG) and astaxanthin (AST) are natural compounds with proved epigenetic immunomodulatory effects in several cell lines. This study has been initiated investigate mechanism (s) whereby EUG AST could enhance DOX cytotoxicity MCF7 cells.Cytotoxic activity alone combined either 1 mM or 40 μM was performed using...

10.1186/s40360-021-00473-2 article EN cc-by BMC Pharmacology and Toxicology 2021-01-28

Abstract: The major limiting factor in long‐term administration of doxorubicin is the development cumulative dose‐dependent cardiomyopathy and congestive heart failure. Although several mechanisms have been suggested to explain exact cause doxorubicin‐induced cardiomyopathy, role vascular endothelium‐derived vasoactive mediators pathophysiology this toxic effect still unknown. Accordingly, present study has initiated investigate whether changes plasma level endothelin‐1 nitric oxide along...

10.1111/j.1600-0773.2001.890305.x article EN Pharmacology & Toxicology 2001-09-01

This study has been initiated to investigate whether sunitinib (SUN) alters the expression of key genes engaged in mitochondrial transport and oxidation long chain fatty acids (LCFA), if so, these alterations should be viewed as a mechanism SUN-induced cardiotoxicity, explore molecular mechanisms whereby carnitine supplementation could attenuate cardiotoxicity. Adult male Wister albino rats were assigned one four treatment groups: Rats group 1 received no but free access tap water for 28...

10.1007/s12012-018-9500-0 article EN cc-by Cardiovascular Toxicology 2019-01-14

This study evaluated the mechanistic sequel of aldehyde dehyrogenase (ALDH2) and Klotho protein in cyclophosphamide (CP)-induced cardiotoxicity rats protective effect astaxanthin (AST) against that sequel. A total 40 male Wistar albino were divided into four groups 10 animals each: Group 1 was injected intraperitoneally (i.p.) with normal saline for successive days. 2 5 days before after a single dose CP (200 mg/kg, i.p.). 3 received AST (50 mg/kg/day, i.p.) 4 as group 3. After last...

10.1111/1440-1681.13598 article EN Clinical and Experimental Pharmacology and Physiology 2021-10-01

Aim The role of surgical castration and rosuvastatin treatment on lipid profile metabolism related markers was evaluated for their prognostic significance in metastatic prostate cancer (mPC) patients. Methods A total 84 newly diagnosed castrated mPC patients treated with were recruited divided into two groups: Group I served as control (statin non-users) while group II Rosuvastatin (20 mg/day) 6 months statin users. Prostate specific antigen (PSA), epidermal growth factor receptor (EGFR),...

10.1371/journal.pone.0278282 article EN cc-by PLoS ONE 2022-12-08

Background: Worldwide, breast cancer is a main cause of morbidity and mortality in females. Doxorubicin (DOX) an anthracycline anticancer drug most commonly employed polychemotherapy protocols the treatment solid hematological tumors. Unfortunately, its optimal clinical benefit limited secondary to rapid development DOX resistance therapeutic failure.
 Aim: Therefore, current study has been initiated investigate possible mechanisms whereby calcium channel blocker Verapamil (VER) could...

10.9734/jpri/2019/v27i630188 article EN Journal of Pharmaceutical Research International 2019-06-07

Abstract Background: Hormonal receptor positive (HR+) breast cancer is the most commonly diagnosed molecular subtype of cancer; which showed good response to doxorubicin (DOX)-based chemotherapy. Eugenol (EUG) and astaxanthin (AST) are natural compounds with proved epigenetic immunomodulatory effects in several cell lines. This study has been initiated improve cytotoxic activity reduce resistance DOX through combination EUG AST MCF7 cells. Methods: Cytotoxic alone combined either 1mM or 40µM...

10.21203/rs.3.rs-39744/v1 preprint EN cc-by Research Square (Research Square) 2020-07-14

Abstract Background: Hormonal receptor positive (HR+) breast cancer is the most commonly diagnosed molecular subtype of cancer; which showed good response to doxorubicin (DOX)-based chemotherapy. Eugenol (EUG) and astaxanthin (AST) are natural compounds with proved epigenetic immunomodulatory effects in several cell lines. This study has been initiated improve cytotoxic activity reduce resistance DOX through combination EUG AST MCF7 cells. Methods: Cytotoxic alone combined either 1mM or 40µM...

10.21203/rs.3.rs-39744/v2 preprint EN cc-by Research Square (Research Square) 2020-08-20

This study examined the mechanism whereby carnitine supplementation attenuates doxorubicin‐induced hepatotoxicity in rats. Male Wistar albino rats were divided into six groups: Rats group 1 injected I.P. with normal saline and served as control; 2, 3 4 every other day doxorubicin (3 mg/kg, i.p.), to obtain treatments cumulative doses of 6, 12, 18 mg/kg. fifth L‐carnitine (200 i.p.) for 10 consecutive plus a dose (18 mg/kg). Administration resulted significant dose‐dependent increase serum...

10.1096/fasebj.25.1_supplement.1018.6 article EN The FASEB Journal 2011-04-01
Coming Soon ...